It takes around 61 hours to identify the pathogen causing a patient’s pneumonia. A new test reduces that to four hours.
Academic rigor, journalistic flair
Articles on Pneumonia
Displaying 21 - 40 of 42 articles
Many patients suffering from COVID-19 exhibit neurological symptoms, from loss of smell to delirium to a higher risk of stroke. Down the road, will COVID-19 survivors face a wave of cognitive issues?
How Kazakhstan failed to deal with COVID-19 and became the first country to enter a second national lockdown.
Dangerous delays may happen at three points: the patient deciding to seek care, reaching a healthcare facility, or receiving quality care at that facility.
Is it possible that people who recover from COVID-19 will be plagued with long term side effects from the infection? An infectious disease physician reviews the evidence so far.
Severe COVID-19 may leave lasting scars in the lungs, but some recovery could happen over time.
S. pneumoniae, the bacteria responsible for pneumonia, causes about one million deaths each year. Now we know how it uses the sugar raffinose to spread through the body to cause disease.
Who is most likely to survive an infection of the new coronavirus? Two immunologists explain that it is those who mount exactly the right immune response – not too weak, not too strong.
Two phrases you hear a lot these days are viral load and infectious dose. What do they mean? Do they reflect the severity of disease or whether someone will get severely ill? Two experts explain.
Because low-income settlements are unplanned, crowded and without sanitation, there are many viral infections that cause health problems.
Genetic analysis indicates novel coronavirus from Wuhan has a 89% similarity to the SARS virus, a relative of the SARS bat virus. However this does not mean nCoV comes from bats.
Chinese scientists sequence coronavirus causing pneumonia outbreak in Wuhan. And it’s never been seen before.
A surprising number of people are catching pneumonia or urinary tract infections in hospital, a new Australian study shows for the first time.
The bacteria that causes melioidosis usually lives 30cm underground in clay soil but is dredged to the surface during heavy rains and floods, and can enter the body through small breaks in the skin.
There have been many advances made in the prevention and treatment of pneumonia, but providing for people’s basic needs can help reduce the disease burden.
People living close to mine dumps are more inclined to show symptoms of asthma.
The risk of bacterial or fungal infection from potting mix is very low. Wearing gloves and washing your hands will keep it even lower.
By committing ourselves to understanding how interventions work on the ground, we have the opportunity to save the millions who die unnecessarily each and every year.
The burden of communicable disease is declining in Africa and life expectancy is increasing. But non-communicable diseases like diabetes, cardiovascular disease and cancer are wreaking havoc.
Understanding the bugs in our lungs could help treat certain diseases, including asthma.
Top contributors
-
Associate Professor, University of Melbourne, Murdoch Children's Research Institute
-
Clinical head, General Intensive Care Unit, Royal Children's Hospital, The University of Melbourne
-
Professor of Veterinary Infectious Diseases, University of Liverpool and International Livestock Research Institute, Kenya, University of Liverpool
-
Lecturer in Virology, Queen's University Belfast
-
Associate Professor of Medicine, Infectious Diseases Physician, Australian National University
-
Senior Lecturer in General Practice, The University of Queensland
-
Professor of Medicine, Pharmacology and Biomedical Engineering, University of Illinois Chicago
-
Assistant Professor of Internal Medicine, Intensivist, University of Michigan
-
Regional Adviser, Immunisation, WHO Regional Office for Africa, Stellenbosch University
-
Associate Professor of Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan
-
Executive Director, National COVID-19 Clinical Evidence Taskforce, and Professor, School of Public Health and Preventive Medicine, Monash University
-
Dean of the Faculty of Medicine and Health Sciences, University of Nottingham
-
Director, Evidence and Methods, National COVID-19 Clinical Evidence Taskforce; Associate Professor (Research), Cochrane Australia, School of Population Health and Preventive Medicine, Monash University, Monash University
-
Medical Epidemiologist at the National Institute of Communicable Diseases and Lecturer at the School of Public Health, University of the Witwatersrand
-
Professor of Infectious Diseases and Microbiology, Australian National University
